Cargando…

Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication

Regulation of cell cycle progression is important for the maintenance of genome integrity, and Polo-like kinases (Plks) have been identified as key regulators of this process. It is well established that Polo-like kinase 1 (Plk1) plays critical roles in mitosis but little is known about its function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Bing, Liu, X Shawn, Liu, Xiaoqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359159/ https://www.ncbi.nlm.nih.gov/pubmed/22309699 http://dx.doi.org/10.1186/1747-1028-7-3

Ejemplares similares

Polo-like kinase 1 (Plk1) regulates DNA replication origin firing and interacts with Rif1 in Xenopus
por: Ciardo, Diletta, et al.
Publicado: (2021)

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
por: Colicino, Erica G., et al.
Publicado: (2018)

Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
por: Biswas, Ayan, et al.
Publicado: (2021)

Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease
por: Song, Bing, et al.
Publicado: (2011)

PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
por: Ruf, Stefanie, et al.
Publicado: (2017)

Pericentriolar matrix (PCM) integrity relies on cenexin and polo-like kinase (PLK)1
por: Aljiboury, Abrar, et al.
Publicado: (2022)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
por: Giordano, Antonio, et al.
Publicado: (2019)

Targeting Echinococcus multilocularis Stem Cells by Inhibition of the Polo-Like Kinase EmPlk1
por: Schubert, Andreas, et al.
Publicado: (2014)

Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)
por: Liu-Sullivan, Nancy, et al.
Publicado: (2011)

Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma
por: Sui, Xianxian, et al.
Publicado: (2020)

Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2017)

A cryptic hydrophobic pocket in the polo-box domain of the polo-like kinase PLK1 regulates substrate recognition and mitotic chromosome segregation
por: Sharma, Pooja, et al.
Publicado: (2019)

Polo-like kinase 1 (PLK1) O-GlcNAcylation is essential for dividing mammalian cells and inhibits uterine carcinoma
por: Yan, Sheng, et al.
Publicado: (2023)

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
por: Harris, Peter S, et al.
Publicado: (2012)

Mechanisms of nuclear pore complex disassembly by the mitotic Polo-like kinase 1 (PLK-1) in C. elegans embryos
por: Nkombo Nkoula, Sylvia, et al.
Publicado: (2023)

Caenorhabditis elegans polo-like kinase PLK-1 is required for merging parental genomes into a single nucleus
por: Rahman, Mohammad M., et al.
Publicado: (2015)

Polo-Like Kinase 1 (PLK1) Is Involved in Toll-like Receptor (TLR)-Mediated TNF-α Production in Monocytic THP-1 Cells
por: Hu, Jinyue, et al.
Publicado: (2013)

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma
por: Ding, Yiming, et al.
Publicado: (2022)

Involvement of Polo-like kinase 1 (Plk1) in quiescence regulation of cancer stem-like cells of the gastric cancer cell lines
por: Zhu, Lin, et al.
Publicado: (2017)

Polo-like kinase 1 (PLK1) and protein phosphatase 6 (PP6) regulate DNA-dependent protein kinase catalytic subunit (DNA-PKcs) phosphorylation in mitosis
por: Douglas, Pauline, et al.
Publicado: (2014)

Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice
por: Ward, Alejandra, et al.
Publicado: (2011)

Polo-like kinase-1 in DNA damage response
por: Hyun, Sun-Yi, et al.
Publicado: (2014)

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes
Publicado: (1996)

Polo-Like Kinase 1(PLK1) Immunohistochemical Expression in Triple Negative Breast Carcinoma: A Probable Therapeutic Target
por: Salama, Maha E, et al.
Publicado: (2021)

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy
por: Li, Zhenhua, et al.
Publicado: (2016)

Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4(+) T cells ex vivo
por: Zhou, Dawei, et al.
Publicado: (2020)

Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cells
por: Raab, Monika, et al.
Publicado: (2019)

Hormonal Induction of Polo-Like Kinases (Plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary
por: Li, Feixue, et al.
Publicado: (2012)

Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB)
por: Bailey, Anders W., et al.
Publicado: (2018)

Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
por: Zhang, Xiaoyang, et al.
Publicado: (2021)

Correction: Hormonal Induction of Polo-Like Kinases (Plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary
por: Li, Feixue, et al.
Publicado: (2012)

Correction: Hormonal Induction of Polo-Like Kinases (Plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary
por: Li, Feixue, et al.
Publicado: (2012)

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment()
por: Liu, Xiaoqi
Publicado: (2015)

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome
por: King, Sharon I, et al.
Publicado: (2012)

Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni
por: Long, Thavy, et al.
Publicado: (2016)

Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
por: Inglis, Kelly J., et al.
Publicado: (2009)

Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015)

The balance of Polo-like kinase 1 in tumorigenesis
por: Lu, Lin-Yu, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jijv7pjd0lm8meccqo5odrddkm